Invention Publication
- Patent Title: GENE EDITING COMPONENTS, SYSTEMS, AND METHODS OF USE
-
Application No.: US18481393Application Date: 2023-10-05
-
Publication No.: US20240141382A1Publication Date: 2024-05-02
- Inventor: Giedrius Gasiunas , Alim Ladha , Vladimir Presnyak , Muthusamy Jayaraman
- Applicant: ReNAgade Therapeutics Management Inc.
- Applicant Address: US MA Cambridge
- Assignee: ReNAgade Therapeutics Management Inc.
- Current Assignee: ReNAgade Therapeutics Management Inc.
- Current Assignee Address: US MA Cambridge
- Main IPC: C12N15/86
- IPC: C12N15/86 ; C12N9/22
Abstract:
The present disclosure provides methods and compositions comprising novel Cas TypeV programmable nucleases and lipid nanoparticles capable of delivering the Cas TypeV programmable nucleases and genome editing systems comprising same. For therapeutic applications, as well as plants and industrial biotechnology.
Public/Granted literature
- US12264328B2 Gene editing components, systems, and methods of use Public/Granted day:2025-04-01
Information query
IPC分类:
